<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01326624</url>
  </required_header>
  <id_info>
    <org_study_id>90D0112</org_study_id>
    <nct_id>NCT01326624</nct_id>
  </id_info>
  <brief_title>Study of the Wearable Defibrillator in Heart-Failure Patients</brief_title>
  <acronym>SWIFT</acronym>
  <official_title>Study of the Wearable Defibrillator In Heart-Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zoll Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zoll Medical Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the safety and efficacy of wearable defibrillator use
      in patients with left ventricular dysfunction or advanced heart failure symptoms, who have a
      high-risk for sudden cardiac death but are either not eligible for an implantable
      defibrillator under current guidelines or are not able to receive the device due to their
      condition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Defibrillation for life-threatening ventricular tachyarrhythmias</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess magnitude and complexity of ventricular and atrial arrhythmias during use</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total mortality</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with wearable defibrillator use</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life with a wearable defibrillator</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications (adverse events) with wearable defibrillator use</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Heart Failure</condition>
  <condition>Ventricular Dysfunction</condition>
  <condition>Sudden Death</condition>
  <condition>Sudden Cardiac Arrest</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Ventricular Fibrillation</condition>
  <arm_group>
    <arm_group_label>NYHA class III or IV</arm_group_label>
    <description>Patients with NYHA class III or IV during the past month and one or more of the following:
Hospitalization for cardiac decongestion and stabilization.
Advanced heart failure receiving intravenous diuretics/inotropics in an outpatient clinic.
Awaiting cardiac transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>left ventricular ejection fraction ≤ 35%</arm_group_label>
    <description>Patients with left ventricular ejection fraction ≤ 35% and either one of the following:
Coronary revascularization within 3 calendar months prior to enrollment.
Heart failure of non-ischemic origin diagnosed within 3 calendar months prior to enrollment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Awaiting ICD re-implantation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute myocardial infarction</arm_group_label>
    <description>Patients hospitalized with acute myocardial infarction and Killip Class III/IV.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>wearable defibrillator (LifeVest)</intervention_name>
    <description>LifeVest wearable defibrillator for unattended treatment of sudden cardiac arrest due to ventricular tachycardia or ventricular fibrillation</description>
    <arm_group_label>NYHA class III or IV</arm_group_label>
    <arm_group_label>left ventricular ejection fraction ≤ 35%</arm_group_label>
    <arm_group_label>Awaiting ICD re-implantation</arm_group_label>
    <arm_group_label>Acute myocardial infarction</arm_group_label>
    <other_name>wearable cardioveter defibrillator</other_name>
    <other_name>WCD</other_name>
    <other_name>LifeVest</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with left ventricular dysfunction or advanced heart failure symptoms (New York
        Heart Association functional Class III/IV), who have a high-risk for sudden cardiac death,
        but are not eligible for an implantable defibrillator or are not able to receive one due to
        their condition.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with NYHA class III or IV during the past month and one or more of the
             following:

               -  hospitalization for cardiac decongestion and stabilization,

               -  advanced heart failure receiving intravenous diuretics/inotropics in an
                  outpatient clinic, or

               -  awaiting cardiac transplantation

          -  Patients with left ventricular ejection fraction ≤ 35% and either one of the
             following:

               -  coronary revascularization within 3 calendar months prior to enrollment, or

               -  heart failure of non-ischemic origin diagnosed within 3 calendar months prior to
                  enrollment.

          -  Patients awaiting ICD re-implantation following device explantation or lead
             extraction,

          -  Patients hospitalized with acute myocardial infarction and Killip Class III/IV.

        Exclusion Criteria:

          -  The presence of an implantable cardioverter defibrillator prior to enrollment.

          -  Advanced cerebrovascular disease.

          -  Non-cardiac terminal illness associated with reduced likelihood of survival for the
             duration of the study.

          -  Use of supplemental oxygen in an outpatient setting requiring an external oxygen tank.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Eldar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chaim Sheba Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14627</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2011</study_first_submitted>
  <study_first_submitted_qc>March 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2011</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>ventricular dysfunction</keyword>
  <keyword>sudden death</keyword>
  <keyword>sudden cardiac arrest</keyword>
  <keyword>ventricular tachycardia</keyword>
  <keyword>ventricular fibrillation</keyword>
  <keyword>wearable defibrillator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

